Classification of Patient Therapeutic Education Programs Components : Etude CONCErTo

NCT ID: NCT02717182

Last Updated: 2019-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-30

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Interest in patient therapeutic education (PTE) is increasing: in France PTE was included within the 2009 "Hospital, Patient, Health and Territory" law as an essential component of the patient healthcare pathway.

PTE is a complex intervention: its delivery is variable and may vary according to its content, functioning, providers, targeted patients, environment and even its objectives. These differences impact the expected results and make difficult the evaluation of PTE interventions. To overcome this difficulty, it is essential to describe precisely the intervention, the processes and the implementation of PTE that are usually not known. PTE interventions need today a global understanding of their mechanisms constituting their complexity.

CONCErTo study aims at developing a classification of the different elements composing a PTE intervention that can impact their results and can ensure their continued existence.

Mechanisms implemented during PTE interventions will be analyzed by a qualitative research. The investigators wish to identify organizational, pedagogical, psychosocial, medical or contextual elements that can impact the results, the patients' participation and the continuity of the program.

The perspective of this research is to improve the understanding of PTE by providing thorough description of the interventions. This work will help stakeholders to better interpret the results of their interventions, to improve the transferability, the implementation and finally to determine which are the elements able to improve patients' health status.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research is an observational study with no intervention. It uses qualitative methods.

The development of the classification consists in 3 phases: a preliminary phase of literature review, an investigation phase and a phase of elaboration of the classification.

Preliminary phase To deepen the questioning of the research, a literature review will be realized on concepts and models as well as on tools and methods used in the published PTE interventions.

Investigation phase

This step uses qualitative methods with 3 types of data collection:

* Semi structured interviews: individual interview will be realized with health care professionals and Therapeutic Patient Education stakeholders (trainers, professional network, decisions makers..). Focus groups will be organized with patients after completion of a therapeutic patient education program.
* In situ observations of the sessions
* Analysis of the documents surrounding the implementation of the interventions: reports, grey literature, applications; the objective is to capture the environment supervising the programs

The investigators plan to include up to 15 programs. However, this number will be adjusted according to the principle of data saturation.

Programs will be selected to ensure variability: the investigators will include hospital based or community based programs, programs led by general practitioners or specialists, with or without patients' implication, recent or experimented programs.

For each program, at least 3 health care professionals and one focus group with patients will be conducted. It will be completed by observation of education sessions.

Other actors (patients' proxies, associations playing a role in the conception or animation of the programs, designers, coordinators, general practitioners, experts of French territorial organization, trainers..;) will complete the data.

The aim of this step is not only to describe the practices but also to interview the experts on the elements they think can impact the results of PTE interventions.

Phase of elaboration of the classification Thematic and content data analyses are scheduled. Concept mapping method will be used to develop the classification.

The classification will be reviewed by experts having not participated to the previous steps.

Validation of the classification :

Applicability and relevance of the classification will be tested with 15 programs in various medical domains.

The classification will then be used in a cohort of patients before and after PTE intervention.

With this classification (or list), recommendations to describe PTE programs will be published.

Eventually, the aim of the recommendations, is to improve the understanding of PTE by providing thorough description of the interventions. This work will help stakeholders to better interpret the results of their interventions, to improve the transferability, the implementation and finally to determine which are the elements able to improve patients' health status.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

interviews

interviews

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients following a patient education program
* professionals involved in a patients education program

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne-Christine Rat

Role: PRINCIPAL_INVESTIGATOR

Nancy Hospital, CIC-EC Inserm CIC 1433; EA 4360 APEMAC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rat Anne-Christine

Nancy, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anne-Christine Rat, MD, PhD

Role: CONTACT

+33383153196

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anne - Christine Rat, MD, PhD

Role: primary

(33) 3 83 15 31 96

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PREPS1439089

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Uncertainty Management Intervention
NCT00938795 COMPLETED NA